The only domain which distinguishes Epstein-Barr virus latent membrane protein 2A (LMP2A) from LMP2B is dispensable for lymphocyte infection and growth transformation in vitro; LMP2A is therefore nonessential.
Using second-site homologous recombination, Epstein-Barr virus (EBV) recombinants were constructed which carry an LMP2A mutation terminating translation at codon 19. Despite the absence of LMP2A or LMP2A cross-reactive protein, the recombinants were able to initiate and maintain primary B-lymphocyte...
Zapisane w:
| Wydane w: | J Virol |
|---|---|
| Główni autorzy: | , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
American Society for Microbiology (ASM)
1992
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC240138/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1328675/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.66.11.6461-6469.1992 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|